Dr. Lauren Finka, a researcher at the University of Lincoln, has developed L-CAT, a new tool for assessing behaviour in cats at rehoming centres and help match them to the ideal new home.
During the course of her PhD studies, which were part funded by COAPE (Centre of Applied Pet Ethology), Lauren discovered inconsistencies in the current models and perceptions of behaviour traits used in re-homing cats.
For example, one of the most common behaviours associated with affection towards humans is the activity of rubbing. Initial results suggested that this is often very inconsistent, as are several other behaviours that were previously thought to to be important in assessing a cat's underlying temperament. Dr Finka’s studies showed that it all depends much more on the specifics of the physical and social context of interactions and that these may change on a daily basis. It was found that on one day a cat might rub against a person ten times, but the next day rub against the same person only once.
The Lincoln Cat Assessment Tool (L-CAT) was developed during this research. COAPE says it is the first of its kind to offer a suitably robust, reliable and easy-to-use way of assessing behaviour in cats at re-homing centres, as well in predicting new owner satisfaction based on those assessments.
The organisation goes on to say that the potential welfare implications of this research are substantial, enabling cats to be properly but rapidly assessed, optimally managed, and suitably matched with would-be owners and thus shortening the length of time cats might spend in the re-homing centre.
L-CAT was tested to establish the possibility of predicting the future behaviour of cats after they had been adopted, as well as gauging how satisfied owners were likely to be with their cats. COAPE says the results generally confirmed that these outcomes were indeed possible, meaning re-homing staff could also use L-CAT to help manage the expectations of owners and potentially improve their satisfaction.
For more information, visit: www.coape.org
The British Veterinary Association has announced the results of the Voice of the Veterinary Profession survey, which found that 84% of veterinary surgeons give up time to work with animal charities and shelters.
72% have a formal arrangement with charities to provide their time and veterinary expertise at a reduced rate, while more than 43% work completely unpaid for animal charities and shelters; treating thousands of abandoned, mistreated or injured animals each year.
The charitable work undertaken by practitioners varied from practice to practice, but included:
On top of all that, veterinary surgeons also provide emergency treatment for stray and wild animals brought in by the public. Although they will sometimes receive a charitable donation towards the cost of treatment through schemes like the RSPCA Initial Emergency Treatment (IET) Scheme, that is by no means always the case.
RSPCA Chief Veterinary Officer James Yeates said: "Vets’ work in this area can go unrecognised but it is appreciated by the RSPCA that they are part of the team trying to help animals. The RSPCA is dedicated to helping animals most in need and relies on vets’ welfare work to help bring a stop to the suffering of all animals."
BVA President Sean Wensley, said: "Behind these statistics are countless stories of veterinary teams – who already often work long, demanding hours – giving their time for free to support animal rescue staff and charities to care for abandoned, injured and neglected animals, as well as help owners to keep and care for much loved animals in times of hardship and crisis. The UK’s network of animal charities and rehoming centres do a fantastic job protecting wild and domestic animals each year. Animal welfare legislation is clear that animal keepers and owners are responsible for meeting their animals’ needs, and prospective animal owners must be aware of the cost and time commitment involved in animal ownership, but we appreciate people’s circumstances can change."
Photo: Javier Brosch/Shutterstock
5m Books has announced the publication of Honeybee Veterinary Medicine: Apis Mellifera L. by Nicolas Vidal-Naquet, a new book written to help beekeepers and anyone involved in apiculture, and environmental organisations better understand how to preserve honeybees as part of a delicate ecosystem.
Honeybee Veterinary Medicine provides an overview of bee biology, the bee in the wider environment, bee diseases and parasites, veterinary treatment, and actions to help support honeybee health.
Honeybees are an essential part of farming and the wider ecosystem, but since the mid-1990s, bee populations around the world have suffered a dramatic decline through a combination of diseases, intoxication, and unknown causes.
5m says that with the depopulation trend continuing, it’s becoming more and more necessary for veterinary surgeons and qualified animal health professionals to become involved in supporting the ecosystem.
Author Nicolas Vidal-Naquet is a veterinary practitioner who graduated in apiculture and Honeybee medicine, and also lectures on honeybee biology and diseases at the Veterinary School of Alfort in France.
Nicolas’ great interest in honeybees was the driving force behind the book, but he is also concerned by the general loss of bees from the ecosystem. He said: "They have a very important role in the pollination of wild flora, crops and orchards, which means they are key actors in sustaining biodiversity and the pollination of crops to feed both humans and animals."
Honeybee Veterinary Medicine is available now in hardback for £60 from http://www.5mbooks.com/honeybee-veterinary-medicine.html
Macahl Animal Health, a new veterinary company which took over the manufacture and distribution of Oralade in the summer, is to make its first appearance at the London Vet Show later this month.
The company will be highlighting its Feed Don’t Fast campaign designed to encourage veterinary professionals to take a much more proactive approach to the early feeding of patients to improve patient outcomes.
Macahl Director Anthony Mackle said, “The Feed Don’t Fast campaign is gathering momentum. We’ve been encouraged by the feedback we’ve had from veterinary practices starting to look at the nutritional needs of their in-patients much earlier than they did before. Rather than waiting to see if a patient will eat or not, they are starting to be more nutritionally-aware, and prioritising feeding in the same way that they prioritise the administration of clinical care or medication. The case studies we’ve received show a clear benefit in early nutrition assisting recovery.
“But we don’t want to sit back and wait for the message to make its own way round: it’s an urgent need. We have to flip the notion of delaying feeding or fasting patients until the gut settles down or they have recovered from whatever condition they were admitted for. Science has moved on. The protocols for human patients recommend early intervention with appropriate nutrition and we need to get this message out to give the same benefits to our pet patients. This is why the educational message of Feed Don’t Fast is so important.”
Macahl says it is making education a key feature of its stand at London Vet Show with technical updates on early feeding of patients and the opportunity to sign up for nutrition and critical care feeding webinars. Staff will be on hand to explain the benefits of early day 1 microenteral feeding to help with the optimal functioning of the gut, and maintenance of the gut-associated lymphoid barrier. The company will be offering a special buy-two-get-one-free LVS promotion on its leading microenteral and rehydration product, Oralade, as well as giving away free dog- and cat-shaped ice cube trays to encourage practice staff to freeze left-over product for further use.
A new website, www.oralade.com will also be launched at London Vet Show which will allow veterinary professionals to access educational materials and videos, and sign up for new and recent webinars.
For more information, visit: www.feeddontfast.co.uk or telephone Macahl Animal Health on (0)28 8778 9245
Royal Canin has announced a new Approved Weight Management Centre programme for vet practices across the UK.
As part of the programme, a number of practices across the UK will receive ‘Centre of Excellence’ status for managing overweight or obese cats and dogs educating clients on prevention.
To gain approved centre status, practices are required to establish a formal Weight Management Clinic and work as a team to refer clients with overweight pets through the clinic. The chosen practices will receive bespoke training from a member of the Weight Management Team, to provide them with the skills and protocols to discuss obesity with clients and encouraging vets, nurses and receptionists to work together to raise awareness of obesity.
Shelley Holden from the Weight Management Team said: "This is a unique platform for practices across the UK to take advantage of and really excel in addressing weight management issues in practice and tackling prevention. We are excited to currently work with an elite group of practices, all committed to raising awareness of obesity in cats and dogs."
Royal Canin has so far given nine clinics 'Centre of Excellence' status. They all now discuss body condition scoring with patients to identify whether the pet is in ideal condition. If overweight or obese, they are then referred for further advice and support to their weight clinic. The weight clinic is a complimentary 30 minute appointment with a weight management nurse, followed by ongoing monitoring, personalised advice and telephone support. Approved clinics also educate owners about prevention during puppy parties, puppy and kitten vaccinations, and at neutering to ensure owners are aware of the health risks of weight gain from the outset.
Jo Hammett BVSc MRCVS, Owner of The Stocks Vets (pictured right), said: "We have received bespoke training from Royal Canin to achieve centre status, giving our team the confidence to discuss the sensitive issues surrounding weight with clients, in addition to tackling education. This has really helped break down barriers in approaching the topic with clients about their pets’ weight and we are finding they are now much more open with the team during consultations, which is a major achievement in itself."
For more information about the Approved Weight Management Centre programme, contact your veterinary business manager or visit www.royalcanin.co.uk.
The Bella Moss Foundation (BMF) and Oncore Online Learning have announced the launch of a 2 week online training course developed to help veterinary professionals implement rigorous, tailored infection controls in practice.
Practical Infection Control is delivered online as a fully tutored course and students will have access to Oncore's virtual learning environment which will host a lecture, learning materials and discussion forums.
Course materials and ongoing tutor support and assessment will be provided by VN lecturer and BMF advisor Louise O'Dwyer. As part of the course, students will be able to create and implement their own tailored infection control standard operating procedures for their practice, which will be evaluated by Louise.
Course registration is now open, and as soon as a minimum of eight students are booked, the first two week course will go live. Practical Infection Control costs £129 and counts for six hours of documented CPD. A percentage of the proceeds will be donated to BMF, to help the charity continue to fund veterinary education and support for pet owners seeking advice on antimicrobial resistant infections.
Louise O’Dwyer said: "This will be a highly interactive course which will be tailored to the individual delegate, and therefore the individual practices. "It will have a different learning format to many other CPD courses, being interactive and very much driven by delegate feedback, meaning those undertaking the course can gain the specific information they need on aspects such as prevention of surgical site infections, cleaning and disinfection, surgical patient preparation and hand hygiene."Jill Macdonald, RVN and founder of ONCORE Online Learning, said: "Infection control is a key component of any practice routine, but in my experience having clear and up-to-date practice guidelines and protocols – that everyone actually uses – can sometimes be overlooked.
"This module, especially timely given new official focus on infection safeguards in the PSS, will empower nurses and other staff to implement the most recent and robust infection control methods, whatever their place of work, whether it be a small local practice or a large veterinary hospital."
To register for Practical Infection Control or find out more about the range of courses offered by ONCORE, visit www.oncoreepd.co.uk or contact info@oncoreepd.co.uk or 07717 335484To find out more about BMF, visit: www.thebellamossfoundation.com
SPVS has announced that Professor Noel Fitzpatrick will appear ‘In Conversation’ with Martin Whiting, lecturer in ethics at the RVC, at the SPVS/VPMA Congress at the Celtic Manor Resort on 29/30th January 2016.
Noel is both an inspirational and a controversial figure. Few would question that his orthopaedic and neurology work has been both brilliant and life saving. Anyone close to him will tell you he is a dedicated workaholic who believes passionately in the sanctity of life.
However, some would argue that programmes like the BBC’s Bionic Vet and Channel 4’s Super Vet may raise expectations among pet owners as to what the average vet practice can do. And then there's the question of just how far practitioners should go to save / prolong an animal's life. Just because you can, does it mean you should?
These are the areas that will be explored in this hour long ‘conversation’ in a format borrowed from literary festivals. There will be an opportunity for the audience to submit their questions from the floor.
For further details and to to book, visit www.spvs-vpma-events.co.uk or call 01453 872731.
Amy Bergs MRCVS, owner of The Cat Doctor in Surrey and co-founder of the new British Mobile Veterinary Association, has won a week's worth of free advertising for her practice on national TV.
The competition was run by the mobile payments company iZettle, which invited entrants to submit a 15 minute video about their business.
Amy's husband and business partner Robert put the video entry together. It was one of seven winners picked out of hundreds that iZettle said it received.
The resulting advert (below) is being shown on a number of TV channels, including Sky News, Sky Sports and Comedy Central, from today.
Amy said: "We are so excited to have won the competition. We love what we do and would like to help more cats, it’s such an amazing opportunity to share what we can offer on national television!"
watch?v=Vi8SCWcPJoo
Vetcel, the veterinary buying group, has announced a partnership with Training Progress, through which it will deliver its health and safety training information to member practices.
Training Progress is a training management system designed primarily so that veterinary managers can track their staff training. The company says the system empowers staff to drive their own training, and devolves training responsibility (where appropriate) away from senior team members.
The tie-up with Vetcel means member practices will be able to access Vetcel's health and safety training in their own own mini Training-Progress site, where they will be able to track their teams' progress and compliance.
Chris Bainton said: "The Vetcel group are delighted to be working with Training-Progress to provide a further benefit to our membership. We recognise that Training-Progress will help our members ensure that their team’s staff development and training is promoted and, specifically, that both the staff and the practices themselves are protected and enabled by monitoring and recording the health and safety training of the team.”
Training Progress will be at stand O54 at the London Vet Show.
Leading human and animal health organisations – the British Medical Association (BMA), British Dental Association (BDA), British Veterinary Association (BVA) and Royal Pharmaceutical Society (RPS) - have joined forces for the first time to promote a ‘One Health’ approach to ensure responsible guardianship of antibiotics and their proper public use on European Antibiotics Awareness Day tomorrow.
Antibiotics are obviously a vital medicine for both animal and human health, and modern health systems rely on the availability and effectiveness of a range of antimicrobials to treat and prevent infections. Yet inappropriate use – such as prescribing for self-limiting infections, not finishing a prescribed course of antibiotics or habitual prophylactic use in healthy animals to prevent disease - all contribute to the development of resistant bacteria in both humans and animals.
Whilst antibiotic resistance in animals does not perhaps present the greatest immediate existential threat, there is a strong argument for a united message to the public coming from doctors, dentists, chemists and veterinary surgeons.
Quite simply, some 13M households own a pet. Pretty much all of them visit a vet at some stage, and most will be a human patient at some point in their lives. So, what a veterinary surgeon says about the use of antibiotics in animals has the potential to help transform how owners think about them when they come to visit the doctor.
A survey of general practitioner doctors last year found that 90% feel pressured by patients to prescribe antibiotics and 28% have prescribed them several times a week when not sure they are medically necessary. If veterinary surgeons refuse to prescribe them for pets unless medically necessary, explaining that they are a precious resource which can no longer be wasted, it could help relieve the pressure on doctors. The same goes for the importance of compliance; if owners learn the importance of their pet taking the full course, there's a greater chance they'll understand why they need to complete their own course of treatment.
BVA President Sean Wensley said: "Antimicrobial resistance (AMR) is too important an issue for uncoordinated approaches amongst the medical professions. We need to work together to share knowledge and successful approaches, as well as taking responsibility for not just the immediate clinical situations before us, but also for our role in supporting the health and wellbeing of wider society. An effective approach to tackling AMR is about professions and patients working together for the greater good."
BMA board of science Chair Professor Sheila the Baroness Hollins said: "Doctors have expressed significant concern about the threat of a ‘post-antimicrobial age’. It is vital that we see action to improve antimicrobial prescribing across all disciplines. Only by different professionals working together to improve antimicrobial stewardship will we start to address this major public health issue."
BDA President Professor Nairn Wilson said: "All health professionals have a responsibility to draw a line under inappropriate or unnecessary use of antibiotics. One in ten prescriptions in the UK are provided by dentists, so we’re determined to do our bit. We are facing a clear and present danger to public health, and it will only be overcome if we act together."
For further information about EAAD 2015, visit www.ecdc.europa.eu/en/EAAD
To mark EAAD 2015, BVA has produced a range of new posters to promote the responsible use of antibiotics for use in veterinary practices or as a source of information for pet owners which can be found on their website www.bva.co.uk/eaad.
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
The RCVS has launched the new Practice Standards Scheme (PSS), which is now open for applications for both practice accreditations and the new system of PSS awards.
Speaking after today’s launch at the London Vet Show, which over 200 veterinary surgeons, veterinary nurses and practice managers attended, Practice Standards Group chair Jacqui Molyneux, said: "The new Scheme is all about offering a pathway to improvement for practices of all shapes and sizes that want to aspire to excellence, and then highlighting these achievements to the animal-owning public in a way that is clear and easy to understand.
"Over half of all veterinary practice premises in the UK are already RCVS-accredited, which is fantastic for a voluntary scheme, but we’d really like to help more practices to get on board. I hope that the improvements and exciting new benefits that we’ve developed will make the Scheme even more rewarding for existing members, and encourage more people to join."
The College says that the main changes to the scheme have been based on feedback from the profession and input from the Practice Standards Group (PSG), with the dual aims of making it more accessible for those practices which aren’t yet PSS members, and even more rewarding for those who are already accredited.
Whilst retaining the existing accreditation levels across small animal, equine and farm animal practices (current RCVS-accredited practices will be automatically transferred to the new Scheme), a new modular structure helps to make the Scheme more flexible and ensure all types of veterinary practice – from ambulatory services to veterinary hospitals – can join. This structure also recognises the contributions of the whole practice team, helping to raise standards across the board.
Once accredited, practices can now apply for a range of optional awards that focus on outcomes and behaviours in specific areas, such as ‘In-patient Service’, ‘Team and Professional Responsibility’ and ‘Client Service’. Designated at either ‘Good’ or ‘Outstanding’, these awards should help clients understand where a practice excels, and what skills and services are on offer, enabling them to make choices based on their needs and preferences.
The RCVS has also recruited and trained a new team of assessors, who will take more of an interest in listening to practice staff rather than just checking paperwork and equipment. It has also developed an online administration and support tool – nicknamed Stanley – to provide document storage, a calendar and a self-assessment function, to make the accreditation and awards application processes quicker and easier to manage.
As an introductory offer, the RCVS is now inviting applications from practices that would be willing to help with a final round of testing of the new Scheme, to be in with a chance to win one of 20 free assessment days, worth £350. The offer is open until Friday 4 December, and the first 20 practices drawn at random on 7 December will be allocated the free assessments.
Full details about the draw, the new Scheme and how to apply for accreditation and/or awards are available at www.rcvs.org.uk/newpss. The new promotional video shown above can also be viewed here.
The RCVS and the BVA have published the Vet Futures report: their vision for how the veterinary profession should look in 2030, coupled with 34 recommendations for change.
The report, which represents the culmination of a year of engagement, consultation and research with the veterinary profession, veterinary nurses, members of the wider veterinary team, key stakeholders, animal owners and the general public, says that in 2030 vets should be a leading force for animal health and welfare and valued for their wider roles in society. They should be confident, resilient, healthy and well supported, and benefit from exceptional leadership. And there should be a broad range of diverse and rewarding veterinary careers, as well as thriving, innovative and user-focused businesses.
While the focus of Vet Futures has been on veterinary surgeons, Vet Futures engaged with the RCVS Veterinary Nurses Council and British Veterinary Nursing Association, as well as individual veterinary nurses, and the College says that many of the ambitions should resonate with members of both professions. It goes on to recommend that the veterinary nursing profession should build on the work of Vet Futures to develop its own clear vision and ambitions.
The recommendations within the report include:
Other recommendations include developing an animal welfare strategy for the profession, increasing collaboration with medical professionals and environmental organisations, adopting a more strategic long-term outlook for research funding, and exploring how to encourage a more diverse profession.
RCVS President Bradley Viner said: "The Vet Futures report is the culmination of a year of research and engagement with thousands of members of the veterinary and veterinary nursing professions, which has given us a very firm foundation on which to build our ambitions and recommendations. We are extremely grateful to every individual who has contributed in some way to the project, and helped us to seize the initiative.
"Over the years the veterinary profession has proved itself to be adaptable and able to face challenges head on, and we have no doubt that by working together we will realise our joint vision of a profession in charge of its future. Ultimately, we all want a profession that is confident in itself and one in which members are proud to call themselves veterinary surgeons."
Sean Wensley, BVA President, added: "Vet Futures has proved to be an exciting, engaging and truly ambitious project for the veterinary profession and it has created a fantastic level of debate and engagement.
"The report we are launching today is not the end of the story; it is the beginning of the next chapter. It is crucial that we maintain the momentum of the project so we will be inviting members of the veterinary professions to step forward and join a new Vet Futures Action Group to help us turn the recommendations into actions and drive forward activity."
The full report can be downloaded here.
Lindsay Newell, a Derbyshire veterinary nurse, has been struck off by The Veterinary Nurses Disciplinary Committee of the RCVS, after she was found guilty of the unlawful possession of veterinary medicines and failing to give regard to welfare in respect of six animals.
The hearing for Ms Newell, who did not attend and was not represented, concluded on 18th November 2015. It related to two main charges against her. The first was that, on 29 November 2012, she was found in possession of a number of veterinary medicines without lawful permission.
The Committee heard that the RSPCA and police officers had attended Ms Newell’s home on that day, where they found veterinary medicines, including controlled drugs, stored in an insecure cabinet within an insecure shed. It heard that during a police interview, she agreed that she was not allowed to possess some of the drugs and subsequently accepted a police caution, which the Committee took as an admission of the offence and therefore found the charge proved.
The second charge was that, between 1 and 29 November 2012 at the Burton Wildlife and Rescue Centre in Etwall, Derbyshire, she failed to give any or sufficient regards to the welfare of six animals in her care. These charges relate to an RSPCA investigation of the rescue centre on 29 November 2012 which found two animals dead and the rest of the animals emaciated and in poor physical condition.
The animals included a male lamb found dead in its pen, a ‘furry-faced’ lamb which died just over a week after the investigation took place, a female goat which died 12 hours after being taken to a veterinary practice for treatment and a pig which died during the investigation process, as well as an adult ewe and a pony which both survived. The charge against her also cited her failure to supply an adequate diet, obtain any or any adequate veterinary attention and explore and address the cause of the weight loss for these animals.
The Committee found all parts of the second charge proved and was satisfied that Ms Newell failed to give sufficient regard to animal welfare as is required by the RCVS Code of Professional Conduct for Veterinary Nurses.
In deciding its sanction, the Committee considered a number of aggravating factors in this case. It found that, in respect of both charges, the misconduct was “sustained over a period of time rather than being a single and isolated incident” and that, in respect of the second charge, that there was “actual harm caused to animals, which resulted in the deaths of four out of the six animals.”
The Committee felt that this constituted reckless disregard for animal welfare rather than deliberate acts but, nevertheless, said that these animals unnecessarily suffered for a period of at least four weeks due to inadequate diet and that, as rescue animals that were already vulnerable, the expectation was that they would be given the appropriate level of care. It also found that Ms Newell had demonstrated limited insight into her behaviour. Furthermore, it considered that a Magistrates’ Court had also disqualified Ms Newell from keeping sheep, goats, pigs, and equines for a period of five years.
In mitigation it considered that Ms Newell did show some insight into her behaviour in relation to the first charge by making admissions during her police interview, as well as the fact that the animal sanctuary, which opened in 2008, had no complaints or cause for concern prior to 2012.
Ian Green, chairing the Committee and speaking on its behalf, said: “The Committee is of the opinion that removal of Ms Newell’s name from the Register of Veterinary Nurses is the only appropriate sanction based upon the severity of the facts found proved.”
International Cat Care has announced the winners of four new ‘Easy to Give’ awards and three ‘Cat Friendly’ awards.
The Easy to Give award was created to reward pharmaceutical companies whose products are easy to administer to cats. Previous examples have included drugs in a highly palatable form, smaller tablets, longer lasting preparations or those with an easier mode of administration.
Easy to Give winners this year are Virbac's Prinovox (ectoparasiticide), Norbrook'sLoxicom (NSAID), and Ceva's Vectra Felis (ectoparasticide) and Zodon (antibiotic).
These latest winners bring the total number of Easy to Give awards presented, since their inception in 2005, to 35.
International Cat Care CEO, Claire Bessant, said: ‘It is so important that cats receive treatments prescribed for them, whether it is for preventive care or to treat a problem. If a drug is too difficult to get into the cat, owners often fail to complete the course, leaving the cat inadequately treated – as we worry about antibiotic resistance, this is particularly important beyond the individual animal too. Struggling with a cat to medicate can put a tension into the owner/cat relationship at a time when owners feel they want to be more supportive rather than seen as something to fear. This year we asked those trying the products if the act of medication had a negative effect on their relationship with their cat, as many people find that in the struggle to medicate, often the cat becomes fearful or aggressive towards them which owners also find very distressing. This kind of innovation by pharmaceutical companies is essential to feline health.’
Easy to Give awards are confined to prescription only medicines (POMs) or methods of delivering POMs. International Cat Care also recognises other products which have made a difference to cat wellbeing and welfare, with its Cat Friendly Awards.
The Cat Friendly Awards go to the SoftE Smart Collar from MDC, the SureFeed Microchip Pet Feeder from SureFlap and the Cat Carrier Tree from Royal Canin.
For more details on the work of the charity go to www.icatcare.org.
Bayer Animal Health has announced the launch of three new educational videos which look at some common concerns in the profession about antimicrobials, including owner compliance, laboratory testing, and prescribing policies in different clinical scenarios.
The videos follow research conducted by Bayer as part of its Veraflox What Lies Beneath campaign in which 73% of veterinary surgeons cited owner compliance as a frequent cause of treatment failure when tackling bacterial infections, and only 5%1 of vets said that they send samples for culture and sensitivity testing routinely in cases where they suspect bacterial involvement.
In the first video presentation, Matt Jones, Microbiology Manager at IDEXX Laboratories, focuses on the importance of culture and sensitivity testing, and how to interpret results from these tests. Matt discusses the merits and drawbacks of various testing techniques available, both in-house and from external laboratories.
In the second presentation, Liz Watkins, founder of Chunk Training, a veterinary training provider which specialises in customer service, provides communication tips to improve consultation technique and increase owner compliance when a course of antimicrobials has been prescribed.
In the final presentation, Ian Battersby, Recognised Specialist in Small Animal Internal Medicine at Davies Veterinary Specialists answers commonly asked questions submitted by vets about antibiotics. Questions include how to adopt a practice antimicrobial policy, how to decide when it is appropriate to use antibiotics in GI disease and how to approach cases that are not responding as expected to antimicrobial treatment.
Hannah Watts, Group Product Manager at Bayer said: ‘‘The issues highlighted by the research need to be addressed in order to help promote responsible antimicrobial use. One of the key findings from the survey was the relatively low number of culture and sensitivity tests that are routinely performed. This may in part be due to financial constraints, but in addition to assisting in appropriate antimicrobial selection, culture and sensitivity tests often save money for the client in the long run, as well as helping to resolve the condition as quickly as possible, leading to improved treatment outcomes for the pet.‘’
Watching the videos can be used to count towards your annual CPD requirement. They're now available at www.vetcentre.bayer.co.uk.
Moral Maze, a debate held by members at the British Equine Veterinary Association (BEVA) Congress earlier this month, has concluded that equine practice needs to adapt to accommodate family life.
92% of voters agreed with the motion: Equine practice needs to change to become more compatible with family life.
BEVA says the result may reflect in part the changing demographics of the profession, with females now accounting for 76% of new graduate intakes.
Traditionally vets have worked together in practices, able to share resources and expertise as well as the out-of-hours rota. Until recently, men from the Baby Boomer Generation dominated the profession and many vets focused their efforts on work at the expense of their family. However, as Generation Y takes hold and more females are joining equine practice, there are different personal expectations with many vets now wanting greater commitment to family life and a better work-life balance.
The session took the form of a moral maze debate, chaired by Malcolm Morley, in which expert witnesses were challenged by informed interrogators. The proposers contended that it is possible to achieve a good work-life balance as an effective vet in a successful equine practice by working smarter, not harder and adopting a flexible approach.
Carolyne Crowe, veterinary coach and mentor, said: “Choosing to be an equine vet shouldn’t go hand in hand with giving up the rest of your life. Allowing flexibility within job roles should result in more engagement, productivity and thus economic benefit for the practice.”
Job share that included a proportionate allocation of the out-of-hours rota, was cited as a tenable solution for those juggling maternity leave and parenthood. The consistency of attending vets so often demanded by clients could be achieved by introducing two vets of equal calibre to the client, from the outset. Members of the audience outlined successful examples of job sharing and the consensus was that the turnover generated by part time, job share employees was often higher than their full time equivalents.
Mark Bowen, President of BEVA, said: “I’m not surprised that 92% of voters supported the motion, given the fact that the recent Vet Futures survey has shown a high rate of job dissatisfaction in equine practice. It reiterates the importance of moving with the times to evaluate the needs of working parents and make the equine veterinary workplace more adaptable to family life.”
BEVA is already working on various projects to help address and support the needs of members who are striving for a better work-life balance. CPD on personal effectiveness, covering work-life balance and time management is scheduled for the New Year. Further information on other initiatives will be released towards the end of the year.
The debate can be viewed online for free at beva.org.uk in the webinar tab.
Davies Veterinary Specialists (DVS) has announced that it has completed development work on its premises in Higham Gobion, Hertfordshire, to improve capacity and workflow for diagnostic procedures including MRI, CT and endoscopy.
The new development includes the construction and outfitting of an anaesthesia induction room with two state-of-the art stations, a diagnostic imaging viewing room, a further ultrasound and procedures room and office space for the nurse supervisor team. The rooms were built inside the site’s central barn as the next phase of DVS’s ongoing expansion programme, which has recently seen the completion of a new staff room and upgraded kennels and cattery facilities.
Clive Elwood, Managing Director of DVS said: “We first acquired the barn space in 2004 and initial construction included MRI and CT rooms with the plan of completing further rooms as needs arose. This latest development has already had a big impact on workflow and allows us to optimise the use of our diagnostic equipment. It represents our continued commitment to growth and development so that we can serve our customers to the best of our ability. I am very grateful to all of those who contributed to the project and showed necessary patience during construction.”
DVS now employs more than 35 specialist clinicians, 60 nurses, many with an advanced nursing qualification, and 30 administrators and support staff.
For further information visit www.vetspecialists.co.uk. You can also follow DVS on Facebook at http://www.facebook.com/DVSvets.
Merial has published Give Them Just What they Need, a guide to the key considerations concerning the vaccination of cats.
The company says it produced the guide after conducting research in which 76% of small animal veterinary surgeons said they are not fully aware of the most recent feline vaccination guidelines, and 98% said they'd find a guide useful.
The survey1, which was conducted amongst 114 UK small animal vets, also showed that whilst 82% of vets are aware of the existence of feline vaccination guidelines from organisations such as the World Small Animal Veterinary Association (WSAVA) and European Advisory Board on Cat Diseases (ABCD), 58% don’t know the content well, and a further 18% were not aware of the guidelines at all.
In a concurrent survey of 1000 cat owners2, 60% said they would have more confidence in their vet knowing that they were vaccinating according to the latest guidelines. The cat owner survey also found that 80% rely on their vet for information about vaccination, and 60% would like more information about vaccination.
Claire Edmunds, product manager at Merial, said: "Understanding that vets are busy people and using all of the insight that we have gathered from vets and owners to shape the content of the guide, we have condensed previously published vaccination recommendations from organisations such as WSAVA and ABCD into really useful, practical advice. The new guide and complementary support materials will hopefully prove to be really valuable resources for vets, giving them the information they need when reviewing their vaccination protocols, in a quick, easy-access format.
"By being better informed about the latest recommendations, we want vets to feel more confident in discussing all aspects of vaccination with their clients. With the majority of cat owners saying that they rely on their vet for vaccination information and nearly half stating that their vet clearly explaining the benefits of vaccination would increase their compliance in vaccinating their cat, this obviously will be beneficial to both the practice and pet cats."
Merial has also produced supporting materials for use alongside the guide, including a take-home leaflet for owners and digital assets for social media and newsletter use, designed to help vets start discussions about vaccination.
Give Them Just What they Need is available from your regional Merial Territory Manager or for download at https://goo.gl/7Uas3y
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.
Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear, colourless solution for injection containing ketamine 100 mg/ml (equivalent to 115.36 mg/ml ketamine hydrochloride) with benzethonium chloride 0.1 mg/ml as a preservative. It can be used to induce anaesthesia in horses in conjunction with xylazine, detomidine or romifidine.
Ketavet, along with other ketamine containing products, has been moved to Schedule 2 of the Misuse of Drugs Regulations, which took effect from 30 November 2015. This enables tighter controls on the record keeping, prescribing and safe custody of products containing this active. More information on the specific requirements which will need to be met following the schedule change can be found on the VMD website https://www.gov.uk/government/news/amendments-to-the-misuse-of-drugs-regulations-2001
Penny McCann, Equine Product Manager at Zoetis said: "Ketavet is an important product in our anaesthesia portfolio. We are keen to help veterinary surgeons keep up-to-date with the reclassification of ketamine and with this in mind our new product packaging clearly reflects ketamine’s revised status as a schedule 2 drug."
For more information, contact your Zoetis Account Manager.
Animalcare has launched Vetaclean, a new range of disinfectants which the company says has a notably high kill activity against canine parvovirus and common feline viruses such as FIV, FeLV and FCV.
The range comprises Vetaclean Parvo Advance, a surface disinfectant-cleaner, Vetaclean enzymatic instrument detergent-cleaner, and an instrument disinfectant.
Animalcare Product Manager, Tony Liepman, said: "Veterinary nurses tell us that canine parvovirus is the most challenging and resistant pathogen they work with, and so we set this as our benchmark for the Vetaclean disinfectant products. Tested under EN protocols and having 99.99% + kill activity against parvovirus, our new disinfectants demonstrate high efficacy against a broad range of bacteria, including MRSA/MRSP, fungi, viruses, mycobacteria and spores.
"Infection control is in the spotlight at the moment, highlighted by initiatives from within and outside our industry. Firstly, the new Practice Standards Scheme - launched at the same time as our range - places great emphasis on having a rigorous biosecurity policy. This includes requirements for personal hygiene as well as cleanliness of premises and equipment. High-level decontamination of instruments and equipment is ensured through the Vetaclean two-stage process, which works with even soiled instruments or equipment, and in under 20 minutes. The products have also been designed to be suitable for use on the most specialised equipment seen in today’s practices, including flexible or rigid endoscopes, ultrasonic baths, aspirators, arthroscopes and re-processing machines.
"Importantly, the active ingredients in the Vetaclean range meet the criteria of the new EU Biocides Regulations, policed by the Health and Safety Executive in the UK, which came into effect on 1st September 2015. All products with biocidal activity now need to undergo a complex registration process, ensuring the products are not harmful to people, the environment or animals. The rigorous process may see many disinfectant manufacturers pull out of the market, resulting in less choice. Further, the Vetaclean range does not contain Poly (hexamethylene biguanide) hydrochloride (PHMB). The European Chemicals Agency (ECHA) is currently proposing that PHMB is listed as a category 2 carcinogen."
The Vetaclean Parvo Advance range includes a 1 litre lavender product in a self-dosing bottle, 5 litre apple and lemon-fragranced liquid concentrates and unfragranced large surface wipes. There are two different dilution rates: a general purpose dilution rate for most pathogens at 1:100 (10ml per litre), and a parvocidal dilution rate at 1:50 (20ml per litre). Animalcare says the alkaline-based formula ensures that the products are compatible with a wide range of materials and are non-staining. Both the enzymatic instrument cleaner and instrument disinfectant are available in 2 litre concentrates (incorporating a calibrated dosing reservoir).
The Vetaclean range is available now in wholesalers. The company has also produced a brochure Hygiene in practice, a guide to veterinary infection control from Animalcare, designed to help familiarise veterinary professionals with the principles and uses of the product range. There is also a special launch offer of Buy-4-Get-One-Free available from Animalcare representatives.
For further information, contact Animalcare on 01904 487687, or speak to your regional Animalcare representative: www.animalcare.co.uk/contact-us.
London Vet Specialists (LVS), billed as the capital's first complete-service referral centre, has announced its official opening in Belsize Park.
The centre is headed up by senior surgeon and soft tissue specialist, Dr Janet Kovak McClaran DVM DACVS DECVS MRCVS, former head of the department of surgery at the Animal Medical Center in New York.
Janet leads a team of consultants specialising in internal medicine and surgery, diagnostic imaging, emergency and critical care, anaesthesia and analgesia, and minimally-invasive surgery.
Janet says the new centre was set up to enable London-based vets to access close-by expert help across key areas: "When I was first approached about setting up a referral centre servicing central and greater London, I was surprised that a dedicated facility didn’t already exist. Previously, referring clinicians have had to send clients on long journeys outside of the capital, leading to patient stress and hassle and extra expense for the owners. Now, they have the reassurance of access to a highly-experienced secondary and tertiary level referral team on their doorstep."
The LVS facility boasts a state-of-the-art surgical theatre, complete with a Karl Storz operating tower enabling cutting-edge laparoscopic, thoracoscopic and cystoscopic procedures. The minimally-invasive surgery suite is one of only three such facilities in the UK. An onsite CT scanner, the GE Brivio CT 385, forms part of an array of imaging equipment, operated by European Specialist in Veterinary Diagnostic Imaging, Dr Livia Benigni. The immediate interpretation of even the most-complex of images is designed to allow seamless patient investigation and negate the need for repeated patient anaesthetics.
Internal Medicine consultant Dr Kaye Gugich, formerly of Vets Now Referrals in Swindon, together with board-certified Emergency and Critical Care Specialist Dr Adam Mugford, and Dr Karla Borland, a previous resident in anaesthesia and analgesia at Edinburgh University, complete the consultant team.
London Vet Specialists says it is the only facility in central London to offer a full time specialist surgery service alongside a specialist service in emergency and critical care. Emergency stabilisation and intensive care is available around the clock, with experienced clinicians and a nursing team ensuring continuous supervision, day or night. The LVS specialist surgical team is also on call to the hospital overnight should specialist emergency surgery be required out of hours.
Patient and customer care at LVS is based on the model used by Sydney’s SASH Vets (Small Animal Specialist Hospital). LVS Client Relations Manager Claire Newton helped to develop the SASH system during her time at the advanced referral hospital, which concentrates on delivering the highest standards of patient care, alongside a dedicated support system for the client and referring vet.
Claire said: "From the very start of the referral process, customer care is prioritised. In this we consider that we have two customers; the first, the referring vet, who needs to feel that he or she has an integral role in the ongoing management of the case, and that his or her client is well-looked after. Our second customer, the pet owner or client, needs to be looked after with compassion and respect, and have the ability to speak directly to the clinician in charge of their pet, at any point. Excellent two-way communication is key. We ensure that we listen and respond to the needs of both parties through every step of the customer journey."
For more information on London Vet Specialists, or to speak to Claire Newton about referring a patient, visit www.londonvetspecialists.vet, email Claire.newton@londonvetspecialists.vet, or telephone 0207 4330155.
The RCVS Disciplinary Committee has dismissed an application to be restored to the Register of Veterinary Surgeons from former Wirral-based vet Ian Beveridge.
In May 2013 the Committee had asked the Registrar to remove Mr Beveridge from the Register following a four-day hearing in which he was found guilty of serious professional misconduct after finding that he had treated clients badly, kept inadequate clinical records, was dishonest in his dealings with the RCVS and that animals in his care were placed at risk.
In June 2013 Mr Beveridge, who was not present or represented at the original hearing, then appealed the decision. The appeal was withdrawn in May 2014 which was when Mr Beveridge was formally removed from the Register.
Then, in April 2015, Mr Beveridge applied to be restored to the Register. The Disciplinary Committee met to consider his application in June 2015, however, this hearing was adjourned after new evidence was served to the Committee concerning allegations that Mr Beveridge had ordered prescription-only veterinary medicines when he was not authorised to do so. He was subsequently interviewed by police who took no further action.
In deciding whether Mr Beveridge was fit to be restored to the Register, the Committee heard evidence in regards to the circumstances in which the prescription-only drugs were ordered using his account and delivered to his former practice address which had been taken over by Medivet after he sold the premises to the company.
During the course of the hearing, Mr Beveridge admitted that his account had been used to buy the drugs, but that a part-time member of his staff, who was neither a veterinary surgeon nor a veterinary nurse, had done so without his prior knowledge or approval.
In relation to this evidence Ian Green, chairing and speaking on behalf of the Committee, said: "The Committee takes the view that the unauthorised use of a veterinary surgeon’s drugs account for which he carries the ultimate responsibility is a very serious matter and, of itself, demonstrates that the applicant has at best a cavalier attitude to his work which of itself means that he remains unfit to be on the Register.
"This attitude is further demonstrated by the fact that, even after the first orders were placed in late April and early May 2014, the applicant did not seek clarification from the College of his status following the withdrawal of his appeal against the original Committee’s findings."
In addition to this, the Committee also considered the seriousness of his original failings, the fact that Mr Beveridge’s acceptance of these failings was ‘qualified’, that he had been off the Register for 20 months and the fact that his efforts in terms of continuing professional development had been inadequate and not focused on those areas in need of improvement, among other factors. In mitigation it did consider that Mr Beveridge had demonstrated genuine remorse about previous actions and noted a petition and a large number of letters in support of him from former clients of his practice.
However, the Committee felt that this did not detract from the seriousness of the original failings and, in conjunction with the subsequent unauthorised ordering of veterinary drugs, that the application for restoration must be dismissed.